NP / PA
Ouklilane, Samira
Ouklilane, Samira was paid $89K by Medicaid between May 2021 and Dec 2024, across 5 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 43% of everything it billed.
33Billing provider infoOUKLILANE, SAMIRA
PROVIDENCE, RI 02905
PROVIDENCE, RI 02905
33aNPI1265048250assigned 09/16/2020
33bProvider typeNurse Practitioner
28Total paid$89K
24GClaims2,105
24DCodes billed5
24AFirst – last monthMay 2021 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Rhode Island
Rank by total paid#17 of 110
Median peer was paid$14K
This provider vs. median6.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 241 | $9K | |
| 2022 | 731 | $31K | |
| 2023 | 599 | $27K | |
| 2024incomplete | 534 | $22K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 43% | 1,229 | 1,178 | $39K |
| 84443 | Thyroid stimulating hormone (TSH) | 29% | 352 | 348 | $26K |
| 83036 | Hemoglobin; glycosylated (A1C) | 23% | 417 | 411 | $20K |
| 84439 | 4.2% | 94 | 92 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | 13 | $304.27 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.